Commensal-dependent induction of protective immunity
Commensal-dependent induction of protective immunity
批准号:
9244503
负责人:
GRETCHEN E DIEHL
金额:
$19.52万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-12-01 至 2018-11-30
关键词:
Anti-Inflammatory AgentsAnti-inflammatoryBiological AssayCandidate Disease GeneCellsClinicalColitisColonDataDevelopmentEmployee StrikesEpithelialEpithelial CellsEquilibriumEscherichia coliGene ClusterGenomeGoalsHomeostasisHumanImmuneImmune responseImmune systemImmunityIn VitroIndividualInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInflammatory disease of the intestineInterleukin-10IntestinesKnock-outLeadMediatingMicrobeMicrobial GeneticsModelingMononuclearMusPathogenicityPathologicPathologyPathway interactionsPatientsPhagocytesPhysiologyPopulationProbioticsProcessProductionRegulationRoleShapesSignal PathwaySignal TransductionSymbiosisSystemSystems DevelopmentTestingTherapeutic UsesTissuesWorkantimicrobialbasechemokine receptorcommensal microbescomparative genomicscytokinegene productgenetic elementgenome wide association studyhealingimmune functionimmune system functionin vivointerestintestinal homeostasismembermicrobialmicrobiotamicroorganismmouse modelpathogenprotective effectrepairedresponsetherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
Over the millennia, humans and their microbiota have coevolved a mutually beneficial relationship. Many
essential aspects of host physiology, including immune system development and intestinal homeostasis,
depend on interactions between cells of the intestine, the intestinal immune system, and the microbiota. For
the intestinal immune system, these interactions require that it strike a balance between providing robust anti-
microbial responses to pathogenic microbes while limiting inflammatory responses against the microbiota. To
understand how this balance is achieved and maintained, it is critical to understand the intestinal microbes,
immune cell populations, and signaling pathways involved. Data from our work and others suggest that
CX3CR1 expressing mononuclear phagocytes (MNPs) detect signals from the microbiota and coordinate
intestinal immune responses to promote epithelial integrity and reduce intestinal inflammation. This population
of MNPs is highly phagocytic and is known to secrete both pro- and anti-inflammatory cytokines. In addition,
this cell population has been found to be expanded in the colon of inflammatory bowel disease (IBD) patients
as well as in mouse models of colitis. We hypothesize that CX3CR1+ MNPs recognize specific members of the
microbiota, which in turn dictates their ability to mediate either protective or pathological responses. Changes
in the commensal microbes encountered by CX3CR1+ MNPs would therefore be predicted to impact the
function of these MNPs. As a hallmark of inflammatory conditions such as IBD is dysbiosis, or a shift in the
composition of the microbiota, changes in the commensal microbes encountered by CX3CR1+ MNPs would
directly impact their function. We have identified E. coli that are normal members of the mouse microbiota and
offer different degrees of protection in mouse models of colitis. We will utilize this mouse commensal as well as
E. coli human clinical isolates to understand how colonization with these microbes impacts the effector function
of CX3CR1+ MNPs. We will further determine how these isolates support immune protection in models of
colitis. Finally, with the goal of identifying microbial genetic elements which induce immune protection, we will
utilize comparative genomics-based analysis to identify and subsequently target microbial gene clusters in
these E. coli isolates that correlate with protective immunity. Our overall objective is to determine how specific
members of the microbiota impacts intestinal immunity as the first step in understanding the regulation of
intestinal homeostasis by the microbiota.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Orchestrating intestinal immunity through microbiota-CX3CR1+ cell interactions
-
批准号:10318457
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2017
-
负责人:GRETCHEN E DIEHL
-
依托单位:
Orchestrating intestinal immunity through microbiota-CX3CR1+ cell interactions
-
批准号:10735384
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2017
-
负责人:GRETCHEN E DIEHL
-
依托单位:
海外基金